Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening
Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of...
Ausführliche Beschreibung
Autor*in: |
Johnson, David H. [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2017 |
---|
Schlagwörter: |
---|
Umfang: |
5995 |
---|
Übergeordnetes Werk: |
Enthalten in: Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd - Xia, Jienan ELSEVIER, 2018, official journal of the American Society for Gastrointestinal Endoscopy, New York, NY |
---|---|
Übergeordnetes Werk: |
volume:85 ; year:2017 ; number:3 ; pages:657-6651 ; extent:5995 |
Links: |
---|
DOI / URN: |
10.1016/j.gie.2016.11.012 |
---|
Katalog-ID: |
ELV015433781 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV015433781 | ||
003 | DE-627 | ||
005 | 20230623122503.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180602s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.gie.2016.11.012 |2 doi | |
028 | 5 | 2 | |a GBVA2017020000001.pica |
035 | |a (DE-627)ELV015433781 | ||
035 | |a (ELSEVIER)S0016-5107(16)30749-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 600 |a 670 |q VZ |
084 | |a 51.00 |2 bkl | ||
100 | 1 | |a Johnson, David H. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
264 | 1 | |c 2017 | |
300 | |a 5995 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. | ||
650 | 7 | |a CRC |2 Elsevier | |
650 | 7 | |a SSA/P |2 Elsevier | |
650 | 7 | |a IQR |2 Elsevier | |
650 | 7 | |a MT-sDNA |2 Elsevier | |
650 | 7 | |a CRN |2 Elsevier | |
700 | 1 | |a Kisiel, John B. |4 oth | |
700 | 1 | |a Burger, Kelli N. |4 oth | |
700 | 1 | |a Mahoney, Douglas W. |4 oth | |
700 | 1 | |a Devens, Mary E. |4 oth | |
700 | 1 | |a Ahlquist, David A. |4 oth | |
700 | 1 | |a Sweetser, Seth |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Xia, Jienan ELSEVIER |t Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |d 2018 |d official journal of the American Society for Gastrointestinal Endoscopy |g New York, NY |w (DE-627)ELV000360317 |
773 | 1 | 8 | |g volume:85 |g year:2017 |g number:3 |g pages:657-6651 |g extent:5995 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.gie.2016.11.012 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 51.00 |j Werkstoffkunde: Allgemeines |q VZ |
951 | |a AR | ||
952 | |d 85 |j 2017 |e 3 |h 657-6651 |g 5995 | ||
953 | |2 045F |a 610 |
author_variant |
d h j dh dhj |
---|---|
matchkey_str |
johnsondavidhkisieljohnbburgerkellinmaho:2017----:uttresolntsciiapromnenipcoyednqaiyfooocp |
hierarchy_sort_str |
2017 |
bklnumber |
51.00 |
publishDate |
2017 |
allfields |
10.1016/j.gie.2016.11.012 doi GBVA2017020000001.pica (DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 600 670 VZ 51.00 bkl Johnson, David H. verfasserin aut Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening 2017 5995 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier Kisiel, John B. oth Burger, Kelli N. oth Mahoney, Douglas W. oth Devens, Mary E. oth Ahlquist, David A. oth Sweetser, Seth oth Enthalten in Elsevier Xia, Jienan ELSEVIER Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd 2018 official journal of the American Society for Gastrointestinal Endoscopy New York, NY (DE-627)ELV000360317 volume:85 year:2017 number:3 pages:657-6651 extent:5995 https://doi.org/10.1016/j.gie.2016.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.00 Werkstoffkunde: Allgemeines VZ AR 85 2017 3 657-6651 5995 045F 610 |
spelling |
10.1016/j.gie.2016.11.012 doi GBVA2017020000001.pica (DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 600 670 VZ 51.00 bkl Johnson, David H. verfasserin aut Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening 2017 5995 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier Kisiel, John B. oth Burger, Kelli N. oth Mahoney, Douglas W. oth Devens, Mary E. oth Ahlquist, David A. oth Sweetser, Seth oth Enthalten in Elsevier Xia, Jienan ELSEVIER Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd 2018 official journal of the American Society for Gastrointestinal Endoscopy New York, NY (DE-627)ELV000360317 volume:85 year:2017 number:3 pages:657-6651 extent:5995 https://doi.org/10.1016/j.gie.2016.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.00 Werkstoffkunde: Allgemeines VZ AR 85 2017 3 657-6651 5995 045F 610 |
allfields_unstemmed |
10.1016/j.gie.2016.11.012 doi GBVA2017020000001.pica (DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 600 670 VZ 51.00 bkl Johnson, David H. verfasserin aut Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening 2017 5995 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier Kisiel, John B. oth Burger, Kelli N. oth Mahoney, Douglas W. oth Devens, Mary E. oth Ahlquist, David A. oth Sweetser, Seth oth Enthalten in Elsevier Xia, Jienan ELSEVIER Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd 2018 official journal of the American Society for Gastrointestinal Endoscopy New York, NY (DE-627)ELV000360317 volume:85 year:2017 number:3 pages:657-6651 extent:5995 https://doi.org/10.1016/j.gie.2016.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.00 Werkstoffkunde: Allgemeines VZ AR 85 2017 3 657-6651 5995 045F 610 |
allfieldsGer |
10.1016/j.gie.2016.11.012 doi GBVA2017020000001.pica (DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 600 670 VZ 51.00 bkl Johnson, David H. verfasserin aut Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening 2017 5995 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier Kisiel, John B. oth Burger, Kelli N. oth Mahoney, Douglas W. oth Devens, Mary E. oth Ahlquist, David A. oth Sweetser, Seth oth Enthalten in Elsevier Xia, Jienan ELSEVIER Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd 2018 official journal of the American Society for Gastrointestinal Endoscopy New York, NY (DE-627)ELV000360317 volume:85 year:2017 number:3 pages:657-6651 extent:5995 https://doi.org/10.1016/j.gie.2016.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.00 Werkstoffkunde: Allgemeines VZ AR 85 2017 3 657-6651 5995 045F 610 |
allfieldsSound |
10.1016/j.gie.2016.11.012 doi GBVA2017020000001.pica (DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 600 670 VZ 51.00 bkl Johnson, David H. verfasserin aut Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening 2017 5995 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier Kisiel, John B. oth Burger, Kelli N. oth Mahoney, Douglas W. oth Devens, Mary E. oth Ahlquist, David A. oth Sweetser, Seth oth Enthalten in Elsevier Xia, Jienan ELSEVIER Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd 2018 official journal of the American Society for Gastrointestinal Endoscopy New York, NY (DE-627)ELV000360317 volume:85 year:2017 number:3 pages:657-6651 extent:5995 https://doi.org/10.1016/j.gie.2016.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 51.00 Werkstoffkunde: Allgemeines VZ AR 85 2017 3 657-6651 5995 045F 610 |
language |
English |
source |
Enthalten in Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd New York, NY volume:85 year:2017 number:3 pages:657-6651 extent:5995 |
sourceStr |
Enthalten in Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd New York, NY volume:85 year:2017 number:3 pages:657-6651 extent:5995 |
format_phy_str_mv |
Article |
bklname |
Werkstoffkunde: Allgemeines |
institution |
findex.gbv.de |
topic_facet |
CRC SSA/P IQR MT-sDNA CRN |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |
authorswithroles_txt_mv |
Johnson, David H. @@aut@@ Kisiel, John B. @@oth@@ Burger, Kelli N. @@oth@@ Mahoney, Douglas W. @@oth@@ Devens, Mary E. @@oth@@ Ahlquist, David A. @@oth@@ Sweetser, Seth @@oth@@ |
publishDateDaySort_date |
2017-01-01T00:00:00Z |
hierarchy_top_id |
ELV000360317 |
dewey-sort |
3610 |
id |
ELV015433781 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV015433781</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623122503.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.gie.2016.11.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017020000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV015433781</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5107(16)30749-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Johnson, David H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5995</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SSA/P</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IQR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MT-sDNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kisiel, John B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burger, Kelli N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahoney, Douglas W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Devens, Mary E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahlquist, David A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sweetser, Seth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xia, Jienan ELSEVIER</subfield><subfield code="t">Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the American Society for Gastrointestinal Endoscopy</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV000360317</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:85</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:657-6651</subfield><subfield code="g">extent:5995</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.gie.2016.11.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">85</subfield><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">657-6651</subfield><subfield code="g">5995</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Johnson, David H. |
spellingShingle |
Johnson, David H. ddc 610 ddc 600 bkl 51.00 Elsevier CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
authorStr |
Johnson, David H. |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000360317 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health 600 - Technology 670 - Manufacturing |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 600 670 VZ 51.00 bkl Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN Elsevier |
topic |
ddc 610 ddc 600 bkl 51.00 Elsevier CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN |
topic_unstemmed |
ddc 610 ddc 600 bkl 51.00 Elsevier CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN |
topic_browse |
ddc 610 ddc 600 bkl 51.00 Elsevier CRC Elsevier SSA/P Elsevier IQR Elsevier MT-sDNA Elsevier CRN |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
j b k jb jbk k n b kn knb d w m dw dwm m e d me med d a a da daa s s ss |
hierarchy_parent_title |
Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |
hierarchy_parent_id |
ELV000360317 |
dewey-tens |
610 - Medicine & health 600 - Technology 670 - Manufacturing |
hierarchy_top_title |
Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV000360317 |
title |
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
ctrlnum |
(DE-627)ELV015433781 (ELSEVIER)S0016-5107(16)30749-0 |
title_full |
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
author_sort |
Johnson, David H. |
journal |
Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |
journalStr |
Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2017 |
contenttype_str_mv |
zzz |
container_start_page |
657 |
author_browse |
Johnson, David H. |
container_volume |
85 |
physical |
5995 |
class |
610 610 DE-600 600 670 VZ 51.00 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Johnson, David H. |
doi_str_mv |
10.1016/j.gie.2016.11.012 |
dewey-full |
610 600 670 |
title_sort |
multitarget stool dna test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
title_auth |
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
abstract |
Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. |
abstractGer |
Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. |
abstract_unstemmed |
Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
container_issue |
3 |
title_short |
Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening |
url |
https://doi.org/10.1016/j.gie.2016.11.012 |
remote_bool |
true |
author2 |
Kisiel, John B. Burger, Kelli N. Mahoney, Douglas W. Devens, Mary E. Ahlquist, David A. Sweetser, Seth |
author2Str |
Kisiel, John B. Burger, Kelli N. Mahoney, Douglas W. Devens, Mary E. Ahlquist, David A. Sweetser, Seth |
ppnlink |
ELV000360317 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1016/j.gie.2016.11.012 |
up_date |
2024-07-06T17:41:49.293Z |
_version_ |
1803852405060665344 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV015433781</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623122503.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180602s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.gie.2016.11.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2017020000001.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV015433781</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0016-5107(16)30749-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">600</subfield><subfield code="a">670</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">51.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Johnson, David H.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Multitarget stool DNA test: clinical performance and impact on yield and quality of colonoscopy for colorectal cancer screening</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5995</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Multitarget stool DNA (MT-sDNA) testing is now approved by the U.S. Food and Drug Administration for average-risk colorectal cancer screening. Trials leading to its approval used blinded colonoscopy as the reference standard. In the postapproval screen setting, the clinical performance and impact of MT-sDNA testing on unblinded colonoscopy has not been described. We measured the impact that knowledge of a positive MT-sDNA test result has on colonoscopy yield and quality.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SSA/P</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IQR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MT-sDNA</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CRN</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kisiel, John B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burger, Kelli N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Mahoney, Douglas W.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Devens, Mary E.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ahlquist, David A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sweetser, Seth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Xia, Jienan ELSEVIER</subfield><subfield code="t">Excitation-dependent multi-color emissions in Yb/Er/Eu: Gd</subfield><subfield code="d">2018</subfield><subfield code="d">official journal of the American Society for Gastrointestinal Endoscopy</subfield><subfield code="g">New York, NY</subfield><subfield code="w">(DE-627)ELV000360317</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:85</subfield><subfield code="g">year:2017</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:657-6651</subfield><subfield code="g">extent:5995</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.gie.2016.11.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">51.00</subfield><subfield code="j">Werkstoffkunde: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">85</subfield><subfield code="j">2017</subfield><subfield code="e">3</subfield><subfield code="h">657-6651</subfield><subfield code="g">5995</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.3986187 |